Ordesekimab | m-entrepreneurship.com

Product Name :
Ordesekimab

Search keywords :
Ordesekimab

drugId :
null

Target Vo:
Interleukin-15

Target Vo Short Name :
IL15

Moa_Name:
Interleukin-15 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Genmab A/S

Active Company_Name :
Amgen Inc

Active Indication_Name:
Vitiligo

In Active Indication_Name:
Lymphoma, T-Cell

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cdk5 Rabbit mAb Autophagy
CD31 (YP5047) Mouse mAb Purity & Documentation
Phospho-EGFR (Tyr1173) Antibody: Phospho-EGFR (Tyr1173) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR (Tyr1173). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts